BioSciences

Vivera BioSciences is focused on developing a selection of non-addictive drugs for indications including cardiovascular conditions and central nervous system and fluency disorders. The division pipeline centers around the utilization of TABMELT®, the patient-centric drug delivery alternative for oral and injectable medications. TABMELT® is a sublingual drug delivery system that allows patients to take medicines in seconds by dissolving them under the tongue.

Visit vivera.bio to learn more.

Copyright © 2022 Vivera Pharmaceuticals, Inc. All rights reserved.
This information – including product information – is intended only for certified clinicians in the United States. The products discussed herein may have different labeling in different countries. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.